Suchergebnisse - "Moll-Udina, Aina"

PubPharm (33)

1

Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

enthalten in: Ophthalmology. Retina | 2024

von Izquierdo-Serra, J. | Martin-Pinardel, R. | Moll-Udina, A. | +123

2

Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index : UVEDAI©

enthalten in: Ophthalmology and therapy | 2024

von Pato-Cour, E. | Borrego-Sanz, L. | Domínguez-Álvaro, M. | +16

3

Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database

enthalten in: The British journal of ophthalmology | 2024

von Martin-Pinardel, R. | Izquierdo-Serra, J. | De Zanet, S. | +59

4

Non-invasive biomarkers for close activity monitoring in birdshot chorioretinitis : Optical coherence tomography angiography and beyond

enthalten in: Acta ophthalmologica | 2024

von Moll-Udina, A. | Dotti-Boada, M. | Miguel, L. | +6

5

Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis : real-world effectiveness and safety outcomes at 12 months

enthalten in: International ophthalmology | 2023

von Moll-Udina, A. | Hernanz, I. | Sainz-de-la-Maza, M. | +5

6

Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN ® ) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months

enthalten in: ResearchSquare.com | 2023

von Moll-Udina, A. | Hernanz, I. | Sainz-de-la-Maza, M. | +5

7

Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months

enthalten in: International ophthalmology | 2023

von Moll-Udina, A. | Hernanz, I. | Sainz-de-la-Maza, M. | +5

8

Characteristics and Management of Ocular Involvement in Individuals with Monkeypox Disease

enthalten in: Ophthalmology | 2023

von Pazos, M. | Riera, J. | Moll-Udina, A. | +25

9

Validation of UVEDAI : An Index for Evaluating the Level of Inflammatory Activity in Uveitis

enthalten in: Ophthalmology and therapy | 2023

von Pato-Cour, E. | Martin-Martinez, M. | Borrego-Sanz, L. | +20

ErratumIn: Ophthalmol Ther. 2023 Feb 20;:. - PMID 36808607

10

Correction to : Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

enthalten in: Ophthalmology and therapy | 2023

von Pato-Cour, E. | Martin-Martinez, M. | Borrego-Sanz, L. | +20

ErratumFor: Ophthalmol Ther. 2023 Apr;12(2):1045-1055. - PMID 36683123